Halma plc, trading under the symbol HLMAF on the OTC exchange, is a British company specializing in health and safety devices. On June 12, 2025, HLMAF reported its earnings before the market opened. The company achieved an earnings per share (EPS) of $0.62, slightly below the estimated $0.63. Additionally, HLMAF’s actual revenue was approximately $1.48 billion, just under the estimated $1.49 billion.
During the Q4 2025 earnings conference call, key figures like CFO Carole Jean Cran and Group CEO Marc Arthur Ronchetti presented the full-year results. The call included participation from analysts and researchers from financial institutions such as UBS Investment Bank and Morgan Stanley. This presentation provided insights into Halma’s financial performance and strategic direction for the year.
Despite the slight miss in EPS and revenue estimates, Halma’s shares reached a record high following the announcement of its annual profit exceeding expectations. The company has also provided an optimistic revenue growth forecast for the fiscal year 2026. This positive outlook has contributed to the surge in Halma’s stock price.
Halma’s financial metrics offer a deeper understanding of its market position. The company has a price-to-earnings (P/E) ratio of approximately 44.33, indicating investor confidence in its earnings potential. Its price-to-sales ratio stands at about 5.86, reflecting the market’s valuation of its revenue. The enterprise value to sales ratio is around 6.18, suggesting the company’s total valuation relative to its sales.
The enterprise value to operating cash flow ratio is approximately 32.68, providing insight into Halma’s cash flow generation relative to its valuation. The earnings yield is about 2.26%, offering a perspective on the return on investment. With a debt-to-equity ratio of approximately 0.46, Halma maintains a moderate level of leverage. Lastly, the current ratio is around 2.45, indicating the company’s ability to cover its short-term liabilities with its short-term assets.